Question 1

Does JPMorgan Chase own CCCC stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 4,747,424 shares of CCCC (C4 Therapeutics), worth $20.7M.

Question 2

How many shares of CCCC does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 4,747,424 shares of CCCC (C4 Therapeutics).

Question 3

What is JPMorgan Chase's CCCC position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's CCCC position is worth $20.7M.

Question 4

Is JPMorgan Chase buying or selling CCCC?

Accepted Answer

In Q2 2026, JPMorgan Chase increased its CCCC position by 1,524,370 shares (+47.3%).

Question 5

When did JPMorgan Chase first buy CCCC?

Accepted Answer

JPMorgan Chase already held CCCC in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	4.7M	+47.3%	$20.7M	0.0%	$4.67	39
2026-Q1	Increased	3.2M	+541x	$7.6M	0.0%	$2.63	44
2025-Q4	Increased	5,945	+34.2%	$11,355	0.0%	$1.91	15
2025-Q3	Decreased	4,429	-3.8%	$9,832	0.0%	$2.22	0
2025-Q2	Decreased	4,606	-86.6%	$6,587	0.0%	$1.43	0
2025-Q1	Increased	34,419	+3.0%	$55,071	0.0%	$1.60	15
2024-Q4	Increased	33,409	+29.6%	$120,273	0.0%	$3.60	19
2024-Q3	First report	25,779	-	$146,941	0.0%	$5.70	0

CCCC8 quarters

CCCC
8 quarters